Table 3.
Adverse events occurring within 28-days of artesunate-amodiaquine fixed dose combination treatment of uncomplicated falciparum malaria, by Intention-to-treat analysis
| Adverse event | Number of patients reporting event n (%) |
|---|---|
| Pyrexia | 25 (8.1) |
| Cough | 21 (6.8) |
| Asthenia | 16 (5.2) |
| Abdominal pain | 13 (4.2) |
| Upper respiratory tract infection | 11 (3.6) |
| Headache | 7 (2.3) |
| Diarrhoea | 7 (2.3) |
| Decreased appetite | 5 (1.6) |
| Vomiting | 4 (1.3) |
| Gastroenteritis | 3 (0.97) |
| Pruritis | 3 (0.97) |
| Peripheral swelling | 3 (0.97) |
| Pain | 2 (0.65) |
| Oral pain | 2 (0.65) |
| Restlessness | 2 (0.65) |
| Otorrhoea | 2 (0.65) |
| Dysentery | 2 (0.65) |
| Furuncle | 2 (0.65) |
| Abdominal distension | 1 (0.32) |
| Dyspnea | 1 (0.32) |
| Rash | 1 (0.32) |
| Total | 136 (44.2) |